Home/Filings/4/0001213900-25-004653
4//SEC Filing

COUCHMAN JONATHAN 4

Accession 0001213900-25-004653

CIK 0000316253other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 4:44 PM ET

Size

8.6 KB

Accession

0001213900-25-004653

Insider Transaction Report

Form 4
Period: 2025-01-16
Transactions
  • Award

    Common Stock

    2025-01-16+142,897142,897 total
Holdings
  • Common Stock

    (indirect: By Xstelos Holdings, Inc.)
    130,000
  • Common Stock

    (indirect: By Xstelos Holdings, Inc.)
    130,000
  • Common Stock

    (indirect: In retirement accounts)
    277,237
Footnotes (4)
  • [F1]The Reporting Person was granted Restricted Stock Units that will fully vest upon the earlier of: (i) the first anniversary of the grant date (i.e., January 16, 2026), or (ii) a change of control event.
  • [F2]Shares are owned by Xstelos Holdings, Inc., of which the Reporting Person is the sole officer and controlling person. He controls a majority of the shares of Xstelos Holdings, Inc. through shares held in his personal Roth IRA retirement account and through shares held by Couchman Investments LP, a family investment fund, which he controls and which is owned by him and by a trust for the benefit of his children, of which he is the investment manager. The Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein, except to the extent of his pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that the Reporting Person is a beneficial owner of the securities of the Issuer reported herein.
  • [F3]Shares are owned by Myrexis, Inc., of which the Reporting Person is the sole officer and controlling person. Myrexis, Inc. is controlled by Xstelos Holdings, Inc. The Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein, except to the extent of his pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that the Reporting Person is a beneficial owner of the securities of the Issuer reported herein.
  • [F4]227,237 shares are held in the Reporting Person's personal SEP-IRA retirement account and 50,000 shares are held in the Reporting Person's personal 401(k) retirement account.

Documents

1 file

Issuer

ENZO BIOCHEM INC

CIK 0000316253

Entity typeother

Related Parties

1
  • filerCIK 0001265094

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:44 PM ET
Size
8.6 KB